RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$13.19
−0.53%Margins
Gross margin
50.2%
EBITDA margin
18.4%
EBIT margin
10.6%
Net margin
10.0%
FCF margin
4.6%
8.7%
Return on equity
5.8%
Return on assets
7.7%
Return on invested capital
0.58x
Asset turnover
$432.3M
Cash from operations
$1.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026